Laurion Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Laurion Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-231,400	Closed	-$4.15M	–	1254
2020 Q2	$4.15M	Buy	+231,400	New	+$3.49M	0.05%	243
2019 Q4	–	Sell	-17,500	Closed	-$173K	–	1332
2019 Q3	$173K	Buy	+17,500	New	+$165K	﹤0.01%	933
2018 Q4	–	Sell	-65,000	Closed	-$650K	–	1531
2018 Q3	$650K	Hold	65,000	–	–	0.01%	777
2018 Q2	$822K	Buy	+65,000	New	+$786K	0.01%	842

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Laurion Capital Management's TBIO Position: Q3 2020 in Review

Laurion Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2020, closing a stake of 231,400 shares — an estimated $4.15M sold.

Laurion Capital Management first reported a position in TBIO in Q2 2018 and held it in 4 quarters. The position peaked at $4.15M in Q2 2020. 132 funds tracked by Wall St. Rank hold TBIO as of Q3 2020.

Laurion Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Laurion Capital Management sold 231,400 Translate Bio, Inc. Common Stock shares in Q3 2020, an estimated $4.15M.
Laurion Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Laurion Capital Management's Translate Bio, Inc. Common Stock position peaked at $4.15M in Q2 2020.
132 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2020.

Based on Laurion Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.